Search

Your search keyword '"Altintas, Engin"' showing total 133 results

Search Constraints

Start Over You searched for: Author "Altintas, Engin" Remove constraint Author: "Altintas, Engin"
133 results on '"Altintas, Engin"'

Search Results

1. Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies

2. Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study

3. Acute pancreatitis in Turkey: Results of a nationwide multicenter study

4. Discharge protocol in acute pancreatitis: an international survey and cohort analysis

5. Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study

7. Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies

8. Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study

9. Acid suppression therapy, gastrointestinal bleeding and infection in acute pancreatitis – An international cohort study

11. Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study

19. A New Risk-Scoring System for Colorectal Cancer and Polyp Screening by Turkish Colorectal Cancer and Polyp Study Group

21. The Role of Intravenous Hydration in the Prevention of Post-Endoscopic Retrograde Chola ngiop ancre atogr aphy Pancreatitis.

26. Characteristics of patients with hepatocellular carcinoma: A multicenter study.

29. Gastrointestinal Stent Uygulamaları: Tek merkez deneyimi

30. Sa1414 A NATIONWIDE MULTICENTER STUDY OF ACUTE PANCREATITIS IN TURKEY

32. P-040. Direct-acting antiviral drugs used ın the treatment of HCV Increase cholesterol levels

43. Inflammatory markers C-reactive protein and PLR in relation to HCC characteristics

49. Serum microRNAs; miR-30c-5p, miR-223-3p, miR-302c-3p and miR-17-5p could be used as novel non-invasive biomarkers for HCV-positive cirrhosis and hepatocellular carcinoma

Catalog

Books, media, physical & digital resources